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Abstract  
Aberrant Zn2+-homeostasis is associated 
with dysregulated intracellular Ca2+ release 
resulting in chronic heart failure. In the failing 
heart, a small population of cardiac ryanodine 
receptors (RyR2) display sub-conductance state 
gating leading to Ca2+ leakage from sarcoplasmic 
reticulum (SR) stores, which impairs cardiac 
contractility.  
Previous evidence suggests contribution 
of RyR2-independent Ca2+ leakage through an 
uncharacterized mechanism. We sought to 
examine the role of Zn2+ in shaping intracellular 
Ca2+ release in cardiac muscle. Cardiac SR 
vesicles prepared from sheep or mouse 
ventricular tissue were incorporated into 
phospholipid bilayers under voltage-clamp 
conditions, and the direct action of Zn2+ on RyR2 
channel function was examined. Under diastolic 
conditions, the addition of pathophysiological 
concentrations of Zn2+ (≥2nM) caused 
dysregulated RyR2-channel openings. Our data 
also revealed that RyR2 channels are not the only 
SR Ca2+-permeable channels regulated by Zn2+. 
Elevating the cytosolic Zn2+ concentration to 1 
nM increased the activity of the transmembrane 
protein mitsugumin 23 (MG23). The current 
amplitude of the MG23 full-open state was 
consistent with that previously reported for RyR2 
sub-conductance gating, suggesting that in heart 
failure in which Zn2+ levels are elevated, RyR2 
channels do not gate in a sub-conductance state, 
but rather MG23 gating becomes more apparent. 
We also show that in H9C2 cells exposed to 
ischemic conditions, intracellular Zn2+ levels are 
elevated, coinciding with increased MG23 
expression.  
In conclusion, these data suggest that 
dysregulated Zn2+ homeostasis alters the function 
of both RyR2 and MG23 and that both ion 




During the cardiac cycle, myocardial contraction 
is initiated when calcium ions (Ca2+) influx into 
the cell, bind to and activate the type-2 ryanodine 
receptors (RyR2) located within the dyad. The 
opening of RyR2 channels cause the release of 
Ca2+ from the sarcoplasmic reticulum (SR), 
which results in a transient rise in cytosolic Ca2+. 
Relaxation of cardiac muscle follows when the 
concentration of Ca2+ is sufficiently reduced, due 
to the combined action of RyR2 channel closure, 
extrusion of Ca2+ from the cell, and uptake of Ca2+ 
back into the SR Ca2+ stores.  In addition to Ca2+, 
the activity of RyR2 is in part regulated by Mg2+ 
which helps prevent inappropriate channel 
openings during diastole (1). Given the essential 
role of RyR2 channels in excitation-contraction 
(EC) coupling, it is unsurprising that these 
channels are key players in heart failure and fatal 
arrhythmias, where damaging changes to Ca2+-
homeostasis occur. 
In heart failure, it is thought that RyR2 
channels become abnormally active or ‘leaky’ 
and are unable to remain closed during diastole 
(2,3). This leads to an increase in spontaneous 
Ca2+ spark frequency and dysregulated Ca2+-
handling within the cardiomyocyte, resulting in 
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decreased systolic contraction and irregular 
contractile activity (4,5). In addition to 
inappropriate activity, it has been reported that a 
subpopulation of RyR2 channels preferentially 
gate in a long lived sub-conductance state within 
the failing heart (2). Although it is undisputed that 
RyR2 channels contribute directly to the 
pathology of heart failure, the underlying cause of 
abnormal RyR2 functioning remains uncertain. 
There is also evidence for an RyR2-independent 
mechanism of SR Ca2+ efflux and that these ionic 
fluxes are more strongly activated in disease 
states (6). The identity of this alternative “leak” 
channel is currently unknown. 
Mitsugumin 23 (MG23) is a recently 
identified voltage-dependent non-selective 
cation-conducting channel shown to have 
particular abundance on the 
endoplasmic/sarcoplasmic reticulum (ER/SR) 
membrane (7,8). Very little is known regarding 
the physiological role and function of MG23 but 
given the location of MG23 together with the 
demonstration that it is permeable to Ca2+ it has 
been suggested that it may play a role alongside 
RyR2 in shaping intracellular Ca2+-dynamics and 
to be important in SR Ca2+-leak (8,9).  
In chronic heart failure aberrant Zn2+ 
homeostasis is associated with dysregulated 
intracellular Ca2+-release, reduced cardiac 
contractility, and significantly prolonged 
elevations of systolic Ca2+ (10-12). This suggests 
a key role for Zn2+ in regulating cardiac function. 
Cardiomyocytes contain a small but measurable 
pool of free Zn2+ in the cytosol, which is reported 
to be ~100 pM (13). This basal level of Zn2+ is 
transiently altered during cardiac EC coupling as 
a result of both the influx of Zn2+ into the cell 
through L-type Ca2+ channels and the release of 
Zn2+ from intracellular stores including the 
endoplasmic/sarcoplasmic reticulum (ER/SR) 
(14). We have recently shown that RyR2-
mediated Ca2+-homeostasis is intimately related 
to intracellular Zn2+ levels and suggest that 
physiological levels of Zn2+ are essential in fine-
tuning the release of Ca2+ from the SR during 
cardiac EC coupling (15). We have also shown 
that when Zn2+ levels reach ≥ 1 nM, Zn2+ directly 
activates RyR2 channels and the dependency of 
Ca2+ for channel activation is removed.  
The role of Zn2+ in regulating diastolic 
Ca2+-leak is poorly characterised. Here we 
examine the role of Zn2+ in shaping SR Ca2+-
release. We propose that Zn2+ alters the gating of 
both RyR2 and MG23 and that this is likely to 
play a key role in diastolic Ca2+-leak leading to 
the progression of heart failure and the generation 
of fatal arrhythmias.  
 
Results  
Zn2+ increases RyR2 activity in the 
presence of the endogenous inhibitor Mg2+ - The 
activity of RyR2 is known to depend on its 
interactions and regulation by multiple 
endogenous effector molecules including Ca2+ 
and Mg2+ (1,16-18). Inhibition of RyR2 by Mg2+ 
helps prevent activation of RyR2 during diastole 
(19-21). The mechanism by which RyR2 remains 
sensitive to Ca2+ even in the presence of cytosolic 
free Mg2+ is unknown. Physiological 
concentrations of Mg2+ are thought to be within 
the millimolar range (~1 mM). Interestingly at 
this concentration, cardiac RyR2 channels 
incorporated into planar bilayers respond poorly 
to systolic concentrations of Ca2+ (22,23). In the 
failing heart RyR2 sensitivity to inhibition by 
cytosolic Mg2+ is reduced when compared to 
healthy controls (24).  
To determine if Zn2+ plays a key role in 
relieving RyR2 inhibition by Mg2+, single RyR2 
channels were incorporated into phospholipid 
bilayers and the direct action of Zn2+ at the 
cytosolic face of the channel in the presence of 1 
mM Mg2+ and activating levels of Ca2+ (5 µM) 
was studied (Fig. 1). Using Ca2+ as the permeant 
ion and holding at a command potential of 0 mV, 
in line with previous studies (16,17) , the addition 
of 1 mM Mg2+ significantly reduced channel open 
probability (Po) from 0.26 ± 0.13 to 0.09 ± 0.01 
(Fig1A, p= 0.017; n = 4 - 5). In the continued 
presence of 1 mM Mg2+ the subsequent addition 
of 0.1 nM Zn2+ to the cytosolic face of the channel 
caused channels to gate with a comparable Po to 
Mg2+-free Ca2+-activated control channels (0.17 ± 
0.04 compared to 0.26 ± 0.13; n = 4). This 
suggests that Zn2+ plays a key role in regulating 
channel function enabling RyR2 to operate under 
conditions of systole. When Zn2+ levels were 
further incremented in the range 0.1 nM - 100 nM, 
channel activity was significantly increased from 
Mg2+ treated control channels (Fig. 1A & B). 
However there was no significant difference 
between individual Zn2+ treatments (Fig. 1B).  
Pathophysiological concentrations of 
Zn2+ lead to “leaky” RyR2 channels - In heart 
failure RyR2 channels become inappropriately 
activated during diastole. Since levels of Zn2+ are 
altered in heart failure and can be chronically 
elevated by as much as 30-fold (25), we next 
wanted to investigate whether Zn2+ could 
modulate RyR2 function in the presence of 
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diastolic concentrations of Ca2+ (100 nM) and in 
the continued presence of 1 mM Mg2+ . Using 
Ca2+ as the permeant ion and holding at a 
command potential of 0 mV, when the cytosolic 
free Ca2+ was reduced from 5 µM to 100 nM, as 
expected channel Po was reduced (Fig. 2A). 
Consistent with the role of Mg2+ as an 
endogenous regulator of channel activity, 
addition of 1 mM Mg2+ to the cytosolic face of the 
channel resulted in a further reduction in channel 
Po (Fig. 2A). Under these conditions nearly all 
channel openings were abolished (Fig 2B). 
Addition of physiological concentrations of Zn2+ 
(0.1 nM) did not significantly increase channel 
activity (Fig. 2A & B). However elevation of free 
Zn2+ to pathophysiological levels (~2 nM) 
resulted in a significant increase in channel Po 
(Fig. 2B).  
We next looked at the mean open time of 
RyR2 gating following the addition of Zn2+ under 
diastolic conditions. Channel gating following the 
addition of Zn2+ ≤ 0.2 nM was not significantly 
different compared to openings from Ca2+-
activated control channels (Fig. 2C) suggesting 
that in the presence of physiological levels of free 
Zn2+, channels are still regulated by Ca2+. 
Importantly, elevating the free Zn2+ concentration 
to 2 nM caused channels to gate to a comparable 
Po to those activated by systolic levels of Ca2+ (Po 
values  were 0.35 ± 0.08; and 0.26 ± 0.09; n = 3- 
6) but the mode of gating under these conditions 
was altered (Fig. 2C). Under these conditions, 
channels gated in significantly longer lived open 
states compared to control. This type of gating is 
consistent with Zn2+-dependent openings. 
RyR2 channels are not the only 
sarcoplasmic reticulum Ca2+-permeable 
channels regulated by Zn2+ - In experiments 
where Ca2+-currents were observed, 38% (15/39) 
of our bilayers displayed openings which were 
not characteristic of RyR2 gating (Fig. 3A). Using 
Ca2+ as the permeant ion, construction of a 
current-voltage relationship revealed that this 
other SR Ca2+-permeable channel displayed a 
Ca2+ conductance of 51 ± 1.5 pS (Fig. 3A). This 
is consistent with the single channel Ca2+-
conductance reported previously for the SR ion-
channel MG23 (8). In 31% of our bilayers (12/39) 
where Ca2+-currents were observed we detected 
gating from both RyR2 and MG23 (Fig. 3B). In 
these experiments, reducing the level of Ca2+ to a 
sub-activating concentration (4 nM) by the 
addition of 1 mM BAPTA abolished RyR2 
openings as expected, but MG23 openings were 
still apparent. In the presence of activating levels 
of Ca2+ (5 µM) the addition of 10 mM caffeine, 
which is a known activator of RyR2 (26) 
significantly increased RyR2 activity (Fig. 3C). It 
has been shown previously that MG23 openings 
are very fast and frequent, and that multiple 
channels often gate together in the bilayer in a 
coordinated manner (8). We also observed this 
type of gating when MG23 was incorporated into 
the bilayer. In order to assess channel activity we 
therefore used noise analysis.  When only MG23 
was gating in the bilayer the addition of 10 mM 
caffeine had no effect on MG23 gating (Fig. 3D). 
This reveals that the regulation of MG23 and 
RyR2 is markedly different. 
Zn2+ regulates the activity of purified 
MG23 - The role of RyR2 in SR Ca2+ leak in heart 
failure is widely accepted. Here we investigate if 
MG23 also contributes to the release of Ca2+ from 
SR stores alongside RyR2. In heart failure, 
cardiac cells encounter hypoxic conditions (27).  
We therefore investigated if the protein 
expression of MG23 was altered under conditions 
of hypoxia. Using the cardiac cell line H9C2, 
western blot analysis revealed that the protein 
level of MG23 increased incrementally following 
periods (3-36 hours) of hypoxia (Fig. 4A). Using 
the Zn2+ specific fluorescent indicator ZnAF-2 
DA, we measured the relative cumulative 
fluorescent intensity and show that intracellular 
Zn2+ levels in H9C2 cells are elevated when 
exposed to ischemic conditions (Fig. 4B). This is 
important as dysregulated Zn2+ homeostasis is 
linked with ischemia and chronic heart failure 
(10,11,28-30).  
We next assessed if Zn2+ could directly 
modulate the activity of MG23. MG23 was 
purified from sheep cardiac ventricular tissue 
following previously established methods (8). 
Construction of a current-voltage relationship for 
purified MG23 revealed a single channel Ca2+-
conductance of 49 ± 0.9 pS (Fig. S1). Using Ca2+ 
as the permeant ion, in the presence of 
physiological levels of Mg2+ (1 mM)  and holding 
at a command potential of 0 mV, the addition of 
0.1 nM Zn2+ to the cytosolic face of MG23 had no 
significant effect on channel activity (Fig. 4C & 
D). Interestingly a 10-fold increase in the 
concentration of Zn2+ from 0.1 nM to 1 nM had a 
significant effect on MG23 channel activity (Fig. 
4D).  
Zn2+ does not cause RyR2 sub-
conductance state gating - We next wanted to 
investigate if native MG23 channels provide a 
leak Ca2+ current in response to elevated Zn2+ 
levels when gating together with RyR2. In control 
Zn2+ and SR Ca2+ leak 
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recordings where both RyR2 and MG23 were 
gating, using Ca2+ as the permeant ion and 
holding at a command potential of 0 mV, 
construction of an all points histogram from our 
single channel data displayed two clear peaks 
(Fig. 5A; left). In control recordings, amplitude 
histograms were best fit with a mixture of two 
Gaussian distributions (Fig. 5A; left) displaying 
mean values of -0.47 ± 0.16 pA and -4.03 ± 0.23 
pA (Table 1). These values represent the closed 
and the full open state of RyR2. Under these 
conditions RyR2 activity is low and the number 
of events for the closed state is larger than the 
number of events for the open state. The 
contribution from MG23 is negligible. The 
subsequent addition of 1 nM Zn2+ to the cis-
chamber not only increased RyR2 channel Po but 
also revealed a third peak (Fig. 5A; right). 
Amplitude histograms were now best fit with a 
mixture of three Gaussian distributions (Table 1). 
The smaller open state (-2 ±  0.5 pA) we now 
reveal is within the range of the unitary current 
amplitude that we (Fig. 3A) and others (8) report 
for native MG23 channels when voltage-clamped 
at 0 mV. In bilayers where only RyR2 is gating, 
as expected the addition of 1 nM Zn2+ increased 
RyR2 activity and more events resided in the 
open state (Fig. 5B). However only two peaks 
were ever observed and data were best fit with a 
mixture of two Gaussian distributions (Table 1), 
as there is no contribution from MG23 (Fig. 5B; 
right). 
Previous studies have suggested that in 
heart failure, RyR2 becomes 
hyperphosphorylated at serine-2808/9 which 
leads to the dissociation of the FK-506 binding 
protein 1B (FKBP12.6) resulting in sub-state 
gating (2). We next wanted to assess if Zn2+ 
altered the phosphorylation status of RyR2 at site 
serine-2809. Incubation of isolated SR vesicles 
with 1 nM Zn2+ had no effect on the level of 
phosphorylation at site serine-2809 (Fig. 5C).   
To confirm that Zn2+ does not result in 
RyR2 sub-conductance state gating we prepared 
SR vesicles from Mg23-knockout mice. This 
allowed us to investigate RyR2-mediated Ca2+ 
currents in isolation from MG23. In these 
experiments, we never observed gating from 
MG23 (n=18; Fig. 6A, upper trace). In contrast 
MG23-mediated Ca2+ currents were observed in 
22% (n=5/23) of our bilayer experiments when 
we used SR vesicles prepared from wild-type 
mice (Fig. 6A, lower trace). In these experiments 
MG23 channel activity was significantly 
increased following the addition of 1 nM Zn2+ to 
the cis-chamber (Fig. 6B). SR vesicles prepared 
from Mg23-knock-out mice displayed functional 
RyR2 channel gating (Fig. 6C; n=3/18) and 
consistent with our previous findings addition of 
1 nM Zn2+ to the cytosolic face of RyR2 
significantly increased channel Po (Fig. 6C). 
Construction of all points amplitude histograms 
from our single channel data showed that the 
addition of 1 nM Zn2+ to the cis-chamber 
significantly increased RyR2 activity (Fig. 6D). 
There was no evidence of RyR2 sub-conductance 
state gating. All data were best fit with a mixture 
of two Gaussian distributions representing the 
closed and fully open state of RyR2 (Table 2).  
 
Discussion 
During cardiac relaxation, it is the 
combined effect of both a lowered Ca2+ 
concentration (100 nM) and the presence of 
millimolar levels of Mg2+, which prevent 
unwanted RyR2 channel openings. This is 
important as even a small increase in the open 
probability of RyR2 during diastole will lead to a 
leak of Ca2+ into the cytoplasm, and this will have 
major consequences for normal cardiac function. 
Irregular RyR2 activity is linked to various forms 
of heart failure but the underlying molecular 
mechanisms which cause altered RyR2 channel 
function remain unclear. In this study we reveal 
that in the presence of diastolic Ca2+ levels (100 
nM) and 1 mM Mg2+ small elevations in the level 
of cytosolic free Zn2+ from resting concentrations 
(c.a 0.1 nM) to ≥1 nM results in irregular RyR2 
channel openings. This provides the first 
evidence that dysregulated Zn2+ homeostasis is 
directly linked with leaky RyR2 channels. We 
also reveal that in H9C2 cardiac cells the level of 
intracellular Zn2+ becomes elevated following 
exposure to hypoxic conditions and that this 
coincides with increased protein expression of the 
ER/SR located non-selective cation channel 
MG23. Furthermore, the activity of MG23 is 
significantly enhanced when cytosolic Zn2+ is 
elevated from 0.1 nM to ≥1 nM. MG23 displays 
Ca2+-handling properties suggesting that 
increased channel activity alongside increased 
channel expression may contribute to SR Ca2+ 
leak alongside RyR2. 
Zn2+ dyshomeostasis results in leaky 
RyR2 channels - In cardiomyocytes raised levels 
of intracellular Ca2+ result in a large release of 
Ca2+ from SR stores and this controls 
contractility. In bilayer studies however, the 
presence of millimolar levels of Mg2+ causes 
RyR2 channels to respond poorly to systolic Ca2+ 
Zn2+ and SR Ca2+ leak 
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levels (21,23,31). Under comparable 
experimental conditions we reveal that the 
addition of cytosolic Zn2+ in the range 0.1 nM to 
100 nM, increased RyR2 activity. Our data 
suggest that small changes in the Zn2+ level will 
have a marked effect on RyR2 activity. This 
becomes highly relevant when we consider that 
concentrations of Zn2+ have recently been 
reported to be transiently elevated to ~50 nM 
during Zn2+-signalling events (32). Physiological 
levels of Zn2+ may therefore have the ability to 
fine-tune the activity of RyR2, suggesting a role 
for Zn2+ in regulating graded Ca2+-responses. 
Under diastolic conditions when RyR2 
channels should remain closed the addition of 2 
nM free Zn2+ resulted in abnormally active RyR2 
channels. Under these conditions the mean open 
times of channel openings were significantly 
longer compared to channels activated by systolic 
levels of Ca2+ alone (5 µM). We have recently 
shown that this mode of gating is consistent with 
Zn2+-dependent openings and that RyR2 is likely 
to have multiple Zn2+ binding sites (15). RyR2 is 
now under the control of Zn2+ and is decoupled 
from its regulatory effects of cytosolic Ca2+ and 
Mg2+ which impairs the ability of the RyR2 to 
properly deactivate resulting in high RyR2 
channel activity which may play a direct role in 
SR Ca2+ leak. In cardiac tissue dysregulated Zn2+-
homeostasis is linked with altered contractility 
and heart failure (10,11,29,30,33), but the 
underlying mechanisms of how Zn2+ contributes 
to these cardiomyopathies is not fully understood. 
Spatial imaging of trace elements reveal that in 
heart failure there is a significant accumulation of 
Zn2+ in the left ventricle of cardiac tissue (34) and 
certain cardiomyopathies including diabetic 
cardiomyopathies and ischemia, display 
chronically raised levels of intracellular Zn2+ 
(25,28). Importantly, the accumulation of 
nanomolar concentrations of intracellular Zn2+ 
has been shown to be followed by a concomitant 
reduction in cardiomyocyte contractile function 
and a reduced SR calcium load (35-38), linking 
dysregulated intracellular Zn2+ levels with altered 
Ca2+-homeostasis.  
Intracellular Zn2+ levels are regulated by 
ZnTs (zinc transporters) which move Zn2+ into 
organelles and out of the cell and ZIPs (Zrt/Irt-
like proteins) which mediate the flux of Zn2+ into 
the cell or from organelles into the cytosol. 
Recent evidence links increased Zip12 expression 
in pulmonary vascular smooth muscle to elevated 
intracellular Zn2+ levels as a result of hypoxia, 
suggesting a fundamental role for Zn2+ in 
pulmonary vascular responses (39). Furthermore, 
increased accumulation of intracellular Zn2+ in 
isolated rat cardiomyocytes exposed to hypoxic 
conditions has been attributed to an imbalance in 
expression of ZnTs and ZIPs (30). This is highly 
relevant when we consider that RyRs play a key 
role in hypoxic increases in the intracellular Ca2+ 
concentration (40,41) and that pulmonary 
hypertension is associated strongly with chronic 
heart failure (42,43).  
Recent evidence suggests that in heart 
failure SR Ca2+ leak causes mitochondrial 
calcium overload which triggers mitochondrial 
dysfunction and the production of free radicals, 
which in turn modulates RyR2 function. Reactive 
oxygen species induce the release of Zn2+ from 
zinc-binding metallothionein proteins (44,45) and 
in cardiomyocytes, oxidants increase intracellular 
Zn2+ levels by as much as 30-fold (25). Our recent 
data show that concentrations of Zn2+ ≥1 nM 
directly activate RyR2 removing the dependency 
on Ca2+ for channel activation (15). The data 
presented in this study reveal that elevating Zn2+ 
to 1 nM even in the presence of 1 mM Mg2+ 
results in irregular channel activity. This is 
important as leaky RyR2 channels are considered 
to be the cause of mitochondrial Ca2+ overload 
and dysfunction in heart failure (46). Zn2+ is also 
reported to impair mitochondrial function leading 
to the excess production of reactive oxygen 
species (47,48), suggesting a potentially 
important role for Zn2+ in the feedback loop 
between the SR and mitochondria. 
RyR2 is not the only “leaky” SR Ca2+ 
permeable channel - In heart failure models RyR2 
channels not only display irregular activity and 
are open when they should remain closed but the 
reported mode of channel gating is also altered. In 
failing human and canine hearts Marx and co-
workers reported that ~15% of RyR2 channels 
gated in a long lasting subconductance state (2), 
We show that when Zn2+ levels were elevated to 
concentrations reported to occur in chronic heart 
failure (>1 nM) where RyR2 and MG23 gate 
together, construction of an all points amplitude 
histogram revealed that channel openings resided 
in two open states; one with a mean current 
amplitude consistent with the full open state of 
RyR2 and another with a mean current amplitude 
which is consistent with the unitary current 
amplitude of the reported RyR2 sub-conductance 
state. However this smaller open state is also 
consistent with the mean current amplitude that 
we (Fig. 3A) and others report for MG23 at 0 mV 
(8). Importantly MG23 gating was never 
Zn2+ and SR Ca2+ leak 
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observed using SR vesicles prepared from Mg23 
knock-out mice irrespective of the Zn2+ 
concentration, whereas functional RyR2 channels 
were evident. In these experiments, construction 
of all point histograms from our single channel 
data revealed that Zn2+ increased the activity of 
RyR2 but never resulted in sub-conductance state 
gating. This suggests that when intracellular Zn2+-
levels are elevated to levels similar to those in 
heart failure, RyR2 does not display sub-
conductance gating but rather the activity of 
MG23 is increased. 
Sub-conductance state gating of RyR2 in 
heart failure models is thought to be a result of 
hyperphosphorylation of the channel leading to 
the dissociation of FKBP12.6. When preparing 
our heavy SR vesicles any endogenous FKBPs 
associated with RyR2 are dissociated (49) and 
consistent with other groups (50-52) we do not 
observe high frequency sub-state gating for 
RyR2.  
The role of Zn2+ and phosphorylation at 
serine-2808/9 in heart failure is unclear. 
Cardiomyocytes exposed to micromolar 
concentrations of external ZnCl2 display an 
increased level of RyR2 phosphorylation at this 
site (53). In contrast, phosphorylation at serine-
2808/9 is reduced when heart homogenates are 
incubated with micromolar levels of Zn2+ (12). 
The story is further complicated when we 
consider that there is controversy over the number 
of PKA phosphorylation sites and their associated 
functional effects on RyR2 gating, and perhaps 
more importantly, certain groups fail to observe 
any alteration in RyR2 phosphorylation at serine 
2808/9 in heart failure (51,54). Phosphorylation 
at serine-2808/9 has also been suggested to 
sensitise RyR2 to luminal Ca2+ (55) which is 
thought to lower the threshold for channel 
activation leading to diastolic Ca2+ overload and 
facilitating diastolic Ca2+ leak observed in heart 
failure (56). Although in this study we did not 
investigate the relationship between luminal Ca2+ 
and cytosolic Zn2+ our data show that the 
phosphorylation of RyR2 at serine-2808/9 is 
unaltered when we incubate isolated SR vesicles 
with 1 nM Zn2+. 
Conditions of ischemic heart failure 
result in raised levels of intracellular Zn2+ and 
increased expression and activity of MG23 - It is 
generally considered that the reduced SR Ca2+ 
content in heart failure is a result of reduced Ca2+ 
pumping by SERCA and increased SR Ca2+ leak 
via RyR2. We now provide evidence that MG23 
contributes to SR Ca2+ leak alongside RyR2. Our 
data show that physiological resting levels of Zn2+ 
(0.1 nM) had no effect on MG23 function but 
increasing the Zn2+ concentration to 1 nM 
significantly increased channel activity. 
Importantly we also show that intracellular Zn2+ 
levels are elevated when cardiac H9C2 cells are 
exposed to ischemic conditions and that this 
elevation in the level of Zn2+ coincides with an 
increase in the protein expression of MG23. 
Importantly, changes in MG23 expression in 
H9C2 cells following hypoxia are comparable to 
the reported changes in protein expression of key 
Ca2+-regulatory proteins including SERCA, 
Phospholamban (PLB) and the sarcolemmal 
Na+/Ca2+ exchanger (NCX) that occur in heart 
failure (57-59). Upregulation of MG23 may 
therefore provide a route for increased SR Ca2+ 
release which together with the reduced 
expression and diminished activity of SERCA 
may lead to an imbalance in SR Ca2+ load and 
likely result in impaired contractility observed in 
heart failure. MG23 has been shown to play a role 
in ER-derived cell death following DNA damage 
(60). The increase in MG23 protein expression 
and consequent deleterious Ca2+-release may also 
facilitate cell death signalling pathways in heart 
under pathophysiological conditions. 
We propose that MG23 plays a limited 
role in controlling the release of Ca2+ under 
normal physiological conditions but contributes 
to diastolic Ca2+ leak in response to 
pathophysiological levels of Zn2+.  This is highly 
relevant when we consider that there is evidence 
for RyR2-independent mechanisms of SR Ca2+ 
efflux, and that these fluxes are strongly activated 
in the failing heart (6). Our data reveals that Zn2+ 
is a potent modulator of SR ion channel function 
and will have a major impact on the Ca2+-
handling properties of the cell. 
To conclude, our study reveals a new role 
for Zn2+ in regulating cardiac function through 
direct modulation of SR Ca2+ permeable channels. 
Under normal physiological conditions, we 
propose that intracellular Zn2+ plays a key role in 
controlling the release of Ca2+ from the SR by 
fine-tuning the activity of RyR2. Pathological 
perturbations in Zn2+-homoeostasis will lead to 
SR Ca2+ leak through irregular RyR2 channel 
openings but also the increased activity of MG23. 
These data reveal that RyR2 is not the only ion 
channel contributing towards SR Ca2+ leak and 
suggest a new and important role for Zn2+ in 
regulating Ca2+-homeostasis and cardiac 
function.  
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Experimental Procedures  
Reagents - Chemicals were AnalaR or the 
best equivalent grade from BDH (Poole, UK) or 
Sigma-Aldrich (Dorset, UK). All solutions were 
made in de-ionised water and those for use in 
bilayer experiments were filtered through a 
Millipore membrane filter (0.45 µm pore). 2,2′-
(Ethylenedioxy)dianiline-N,N,N′,N′-tetraacetic 
acid (BAPTA), ATP and the catalytic subunits of 
PKA were obtained from Sigma-Aldrich. 
Generation of Mg-23 knockout mice - 
Mg23-knockout mice were produced using J1 
embryonic stem cells derived from 129/Sv mice 
as described previously (60,61). Briefly genomic 
DNA including murine MG23 exons I–IV was 
purchased from Thermo Fisher Scientific 
(Paisley, UK). A targeting vector was constructed 
with the genomic DNA fragments, neomycin-
resistance gene from pMC1-Neo, the diphtheria 
toxin gene from pMC1-DT-A, and pBluescript 
SK (−) (Agilent Technologies, California, USA). 
Embryonic stem (ES) cells were transfected with 
the linearized vector. G418-resistant cells were 
shown to carry the expected homologous 
mutation as confirmed by Southern blot analysis. 
The founder chimeric mice were crossed twice 
with female C57B6/J mice. The genetic 
background of the resulting heterozygous 
knockout mice was 25 % 129 and 75 % C57B6. 
Mg23-knockout and wild-type littermates (17-29 
weeks old) were obtained by crossing the 
heterozygous mice. The offspring back-crossed 
more than six times with C57BL/6J mice were 
employed for analysis. To determine the mouse 
genotypes, PCR analysis was conducted using the 
following primers: MG23F (5′-
GGCAGGCGCACACAGCACTCCGTTATGG-
3′) and MG23R (5′-
GGGGCAACTTCAGTCCCAACAGAGCTGC
C-3′).  
The institutional ethics committee at the 
University of St. Andrews and the University of 
Kyoto approved the study. Mice were killed by 
concussion followed by cervical dislocation. The 
care and sacrifice of the animals conformed to the 
guidelines from Directive 2010/63/EU of the 
European Parliament on the protection of animals 
used for scientific purposes. Full methods are 
detailed in the supplementary material. 
Single Channel Recording and Analysis - 
Sheep cardiac heavy sarcoplasmic reticulum 
(HSR) membrane vesicles were prepared and 
fused with planar phosphatidylethanolamine lipid 
bilayers, as described previously (15). Sheep 
hearts were obtained from a local abattoir which 
conforms to the European Union directive 
1099/2009 legislation. HSR vesicles from wild-
type and Mg23-knockout mice were prepared in 
an identical fashion to sheep HSR vesicles, with 
the exception that 10 complete mouse hearts were 
used per membrane preparation. Single channel 
current recordings were monitored under voltage-
clamp conditions using a BC- 525C amplifier 
(Warner Instruments, Harvard) using previously 
described techniques (15). The trans-chamber 
was perfused with 250 mM glutamic acid and 10 
mM HEPES (pH to 7.2) with Ca(OH)2 
(concentration of free Ca2+ ~50 mM). The identity 
of RyR2 was confirmed by the single-channel 
conductance, and the number of channels gating 
in the bilayer was assessed by the application of 
500 µM suramin at the end of the experiment. The 
average capacitance of our bilayers was 89 ± 8 pF 
and this was consistent throughout the entire 
recording. Experiments were carried out at room 
temperature (22 ± 2°C). The concentration of free 
Ca2+ and pH of all of our solutions were 
determined using a Ca2+ electrode and a pH 
electrode (Hanna Instruments, Bedfordshire, UK) 
as previously described (15). Zn2+  was added as 
ZnCl2 to the cis-chamber at the required 
concentration from an appropriate stock solution 
as described previously (15). 
Measurements of current amplitude were 
made using the WinEDR 3.6.4 programme. The 
closed and open current levels for both RyR2 and 
MG23 were assessed manually using cursors. All 
points amplitude histograms were obtained from 
single-channel data and constructed using QuB 
software (www.qub.buffalo.edu). Histograms of 
these distributions were fitted with mixtures of 
Gaussian curves using OriginPro software 
(OriginLab, MA, USA). Channel events were 
detected by the 50% threshold method (62) using 
TAC 4.2.0 software (Bruxton Corporation, WA, 
USA). Open probability (Po) was taken from 3 
min of continuous recording. As reported 
previously multiple MG23 often gated together in 
the bilayer (8). When many channels 
incorporated into the bilayer, we used noise 
analysis to estimate channel activity and to 
observe the effects of Zn2+ on channel function. 
Noise analyses of MG23 experiments were 
performed using WinEDR 3.6.4, as described 
previously (63).  
Affinity purification of Mitsugumin 23 - 
MG23 channels were enriched and purified from 
sheep cardiac HSR vesicles. HSR vesicles were 
solubilised for 60 min at 4oC at a protein 
concentration of 2 mg/ml in a 3-((3-




sulfonate (CHAPS) detergent solubilisation 
buffer containing 1% w/v CHAPS, 1 M NaCl, 0.1 
mM EGTA, 0.15 mM CaCl2, 25 mM PIPES and 
2.5 mM DTT. Insoluble material was removed by 
centrifugation for 30 min at 150 000 x g. The 
supernatant was incubated for 120 min with 
protein G sepharose (GE healthcare) cross-linked 
with an αTMEM109 antibody (Sigma-Aldrich). 
The resin was washed in 20 mM TrisHCl, 500 
mM NaCl, 0.1% CHAPS, protease inhibitor 
cocktail P8340 (Sigma) (1:500), 1 mM PMSF, 2.5 
mM DTT (pH 7.4). MG23 protein was recovered 
by overnight incubation with an epitope peptide 
(Genscript) at 4oC. Epitope peptide was removed 
by gel filtration using a HiTrap desalting column 
(GE healthcare). Elution fractions were collected. 
Identification of MG23 within each fraction was 
determined by SDS-PAGE followed by silver 
staining. MG23 positive fractions were snap-
frozen and stored at -80 oC.  
Measurement of free metal ion levels - 
The free Ca2+ concentration of our recording 
solutions was reduced from ~5 µM to 100 nM by 
the addition of 7.6 µM of the chelation agent 
BAPTA. The free Ca2+ concentration was 
measured using a Ca2+-selective electrode. 
BAPTA is known to bind other divalent cations 
including Zn2+ (64), we therefore calculated the 
theoretical concentration of total Zn2+ required to 
be added to our low Ca2+ recording solutions in 
order to result in the appropriate free Zn2+ 
concentration. Free Zn2+ calculations were 
performed using the MIQUV program. Tris 
protonation and Zn2+ stability constants were 
taken from Bologni et al.(65). Calculations were 
performed using the ionic composition of 
TRIS/HEPES recording solutions at room 
temperature (22 ± 2 oC). Calculations assumed a 
starting free [Ca2+] of 3.54 µM, and a starting free 
[Zn2+] of 9 pM. Free [Ca2+] and [Zn2+] were 
calculated in the presence of 7.6 µM BAPTA and 
following the incremental increase of Zn2+ 
concentration in the range 100 pM  to 10 µM. Kd 
values of BAPTA for Zn2+ and Ca2+ were based 
on previously reported values (64,66). The 
calculated values are shown in Table 3.  
Addition of ZnCl2 up to a concentration 
of 10 µM to our BAPTA treated solutions had no 
significant effect on either the measured or the 
calculated free Ca2+ concentration (Fig. 7 & Table 
3). Detection of free Zn2+ was performed using a 
pZn meter (neurobiotex.com, TX, USA)  as 
described previously (15) and determined to be 9 
± 7 pM.  
Cell Culture - H9C2 cells were cultured 
in Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 10% fetal bovine 
serum and 1% penicillin/streptomycin (Life 
Technologies, Paisley, UK) under 95% air/ 5% 
CO2 and sub-cultured between 60-70% 
confluence.  
H9C2 Hypoxia - H9C2 cells were 
subjected to 0.5% O2 in a Don Whitley H35 
hypoxystation (Don Whitley Scientific Ltd., UK). 
Under hypoxic conditions cell lysates were 
collected in RIPA buffer (25 mM Tris HCL, 150 
mM NaCl, 1% NP-40, 1% sodium deoxycholate 
and 0.1% sodium dodecylsulfate (SDS), 
supplemented with protease inhibitor cocktail 
P8340  (Sigma-Aldrich). Lysates were snap-
frozen and stored at -80 oC before use.  
Cellular Zn2+ Measurements in H9C2 
Cells in Response to Ischemia - To simulate 
ischemia H9C2 cells were exposed to an ischemia 
buffer containing 108 mM NaCl, 16 mM KCl, 
0.33 mM NaH2PO4, 10 mM PIPES, 20 mM 
deoxyglucose, 20 mM Na-lactate, 1 mM MgCl2, 
2 mM CaCl2 and 0.2 mM 2,4-dinitrophenol 
(DNP), pH to 6.8 with NaOH. Following 
aspiration of ischemia buffer cells were washed in 
phosphate buffered saline (PBS), and incubated 
with 5 µM ZnAF-2 diacetate (ZnAF-2 DA, 
Chemodex, Switzerland) in PBS in the dark for 
30 min at 37 oC. Cells were subsequently washed 
in fresh PBS followed by 100 µM EDTA in PBS 
before fixing in 4% paraformaldehyde for 10 min 
at room temperature. Cells were then washed 3 
times in PBS. Cells were permeabilized in 0.2 % 
Triton x-100 in PBS for 30 min before loading 
with 10 µM DAPI in PBS for 10 min at room 
temperature. Basal Zn2+ fluorescence intensity 
(excitation 492 nm; emission 514 nm) was 
determined by FLUOstar OPTIMA microplate 
reader (BMG Labtech) and was normalised to 
4’,6-Diamidino-2-Phenylindole (DAPI, Life 
Technologies, Paisley, UK (excitation 358 nm; 
emission 461 nm). 
Western Blot Analysis - HSR proteins or 
H9C2 cell lysates were size fractionated by SDS-
PAGE on a 4-12% Bis-Tris precast gel (Life 
Technologies, Paisley, UK). Following 
separation, proteins were transferred to a 
nitrocellulose membrane and non-specific 
binding sites were blocked for 1 hr at room 
temperature using 5% dried milk and Tris-
buffered saline (0.1% Tween 20, pH 7.4). 
Membranes were probed overnight at 4°C with 
primary antibodies specific for RyR2 
phosphorylated at site serine 2809 (1:5,000, 
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Badrilla, Leeds, UK), anti-MG23 (1:20,000 
Sigma-aldrich) and anti-β-actin (1:10,000, 
Sigma-aldrich) in 5% dried milk and Tris-
buffered saline. Secondary horseradish 
peroxidase linked goat anti-rabbit or anti-mouse 
IgG (both 1∶10,000) Sigma-Aldrich, UK)) 
antibodies were used in combination with an 
enhanced chemiluminescent detection system 
(Thermo Scientific, Paisley, UK) and visualised 
using a Fujifilm LAS-3000 detection system. 
Densitometry was performed using ImageJ 
software (NIH, MD, USA).  
Statistical analyses - Data are shown as 
mean ± S.D. Where appropriate, a Student’s t-test 
was used to assess the difference between mean 
values. Where multiple treatments were 
compared, a one-way analysis of variance 
(ANOVA) followed by a Bonferroni post hoc test 
was used to assess the difference between 
treatments. p values ≤ 0.05 were taken as 
significant. 
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Figure 1 Cytosolic Zn2+ increases RyR2 activity in the presence of 1 mM Mg2+. (A) Representative 
single RyR2 channel traces with Ca2+ as the permeant ion. Bilayers were voltage-clamped at 0 mV. O 
and C show the fully open and closed states respectively. In the presence of activating levels of cytosolic 
Ca2+ (5 µM) the addition of 1 mM Mg2+ reduced RyR2 activity. In the continued presence of 1 mM 
Mg2+, the subsequent addition of Zn2+ to the cytosolic face of the channel increased channel open 
probability. (B) Scatter plot showing the mean channel open probability of RyR2. Individual data points 
are shown by о. Data are expressed as mean ± S.D; n = 3- 5. Significant difference between treatments 
was assessed by a one-way ANOVA; (F(5,18) = 7.276, p = 0.0007) followed by a Bonferroni post hoc 
test. * (p< 0.05) and *** (p< 0.001) indicate significance when compared to Mg2+-treated control.  
 
Figure 2. Under diastolic conditions, pathophysiological levels of cytosolic free Zn2+ result in 
increased RyR2 activity. (A) Representative single RyR2 channel traces. Bilayers were voltage-
clamped at 0 mV and Ca2+ was the permeant ion. Open and closed states of RyR2 are indicated by O 
and C. As expected, RyR2 activity is reduced when the cytosolic [Ca2+] is lowered from 5 µM to 100 
nM and reduced further following the addition of 1 mM Mg2+. The addition of 2 nM Zn2+ to the cis-
chamber significantly increased channel activity. (B) Mean open probability of RyR2. Individual data 
points are shown by о. Data are shown as mean ± SD; n = 3-5. Difference between treatments was 
assessed by a one-way ANOVA followed by a Bonferroni post hoc test. (F(5,21) = 8.133, p = 0.0002). 
* (p< 0.05) and *** (p< 0.001) indicate significance when compared to Mg2+-treated channels in the 
presence of 100 nM Ca2+. (C) Scatter plot showing the mean channel open time. Data are shown as 
mean ± SD; n = 3-5. Individual data points are shown by о. One-way ANOVA followed by a Bonferroni 
test was used to test difference between treatments (F(5,26) = 8.501, p < 0.0001). * indicates 
significance (p ≤ 0.05) compared to Mg2+ treated channels in the presence of 100 nM Ca2+. 
 
Figure 3. Native cardiac MG23 channels displays distinct gating properties from RyR2. (A) The 
left panel shows representative Ca2+-current fluctuations mediated by MG23, recorded at various 
holding potentials. The traces were chosen to show current amplitudes clearly.  The right panel shows 
a current-voltage relationship for MG23 using Ca2+ as permeant ion. Data are shown as mean ± S.D 
(n=5). (B) Representative current fluctuations through both MG23 and RyR2-channels gating in the 
same bilayer under control conditions with Ca2+ as permeant ion at a holding potential of 0 mV. 
Cytosolic free Ca2+ was 5 µM. MG23 (OMG23), RyR2 (ORyR2) open, RyR2 + MG23 (ORyR2 + MG23) open 
and closed (C) states are indicated. Addition of 1 mM BAPTA to the cis-chamber lowers Ca2+ to < 4 
nM. This Ca2+ concentration is sub-activating for RyR2, but has no effect on MG23. (C) The top panel 
shows representative Ca2+-current fluctuations mediated through RyR2 under control conditions with 
Ca2+ as permeant ion. Cytosolic free Ca2+ was 5 µM. Addition of 10 mM caffeine to the cis-chamber 
resulted in activation of RyR2 as expected. The lower panel shows a scatter plot of RyR2-channel open 
probability under these conditions. Data shown are as mean ± SD; n = 3. ** denotes a significant 
difference (p<0.01) to control. (D) The top panel shows representative Ca2+-current fluctuations 
mediated through MG23 under control conditions using Ca2+ as permeant ion. Cytosolic free Ca2+ was 
5 µM. The addition of 10 mM caffeine to the cis-chamber had no effect on MG23-channel activity. The 
lower panel shows a scatter plot of mean average current mediated through MG23 under these 
conditions. Data are shown as mean ± SD; n = 3.  
 
Figure 4. Pathophysiological concentrations of Zn2+ alter both the expression and activity of 
MG23. (A) Upper panel representative Western blot showing MG23 protein expression in H9C2 cells 
exposed to hypoxia. All lanes were loaded with 10 µg total protein. Western blots were probed with 
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antibodies specific for MG23 or with β-actin as a loading control. Size markers are indicated in KDa. 
Lower panel scatter plot showing relative density of MG23 under labelled conditions. Band densities 
were normalised to β-actin loading controls in each lane and expressed relative to control as % 
percentage change. Grey dashed line denotes control values. Data are displayed as mean ± SD (n = 4). 
* denotes a significant difference (p<0.05) to control. (B) Scatter plot showing ZnAF-2 DA fluorescence 
intensity from H9C2 cells exposed to ischemia buffer for indicated time points. For each time point 
ZnAF-2 DA fluorescence was normalised to DAPI nuclear staining fluorescence intensity for each 
corresponding well, and expressed as percentage change from control. Control values are indicated by 
the grey dotted line. Data are displayed as mean ± SD (n = 6) from two individual cell preparations. ** 
Denotes a significant difference (p<0.01) to control. (C) MG23 single-current fluctuations showing 
increased channel activity with increasing concentrations of cytosolic Zn2+, in the presence of 
physiological levels (1 mM) Mg2+. The traces were chosen to show clear channel openings. Cytosolic 
free Ca2+ was 5 µM. Open (O) and closed (C) states are indicated. Holding potential was 0 mV and Ca2+ 
was used as the permeant ion. Multiple MG23 often incorporated into the bilayer, indicated by *. (D) 
Scatter plot showing the mean average current under conditions described in (C). Data are displayed as 
mean ± SD (n = 3). (**) indicates a significant difference (p<0.01) to control.  
 
Figure 5. Zn2+ modulates the activity of both MG23 and RyR2 but does not result in RyR2 
subconductance gating. (A) Representative Ca2+-current fluctuations when both MG23 and RyR2-
channels are gating in the same bilayer (left trace) and following the subsequent addition of 1 nM Zn2+ 
to the cis-chamber (right trace). Cytosolic free Ca2+ was 5 µM. MG23 (OMG23), RyR2 (ORyR2) open, 
RyR2 + MG23 (ORyR2 + MG23) open and closed (C) states are indicated. The corresponding all-points 
amplitude histogram is shown underneath the respective single-channel recording.  Recordings were 
made using Ca2+ as permeant ion and at a holding potential of 0 mV.  (B) Representative Ca2+-current 
fluctuations through RyR2 channels only (left trace) and following the subsequent addition of 1 nM 
cytosolic Zn2+ (right trace). Cytosolic free Ca2+ was 5 µM. Corresponding all-points amplitude 
histogram are shown underneath the respective single-channel recording. (C) Left panel western blot 
analysis showing the phosphorylation of RyR2 at site serine 2809 following incubation of cardiac HSR 
vesicles with either 1 unit/µg protein of the PKA active subunit, 0.1 nM Zn2+ or 1 nM Zn2+. In all 
experiments 1 mM Mg2+ and 1 mM ATP were present. All lanes were loaded at 30 µg total protein. 
Western blots were probed with antibodies specific for RyR2 phosphorylated at site serine 2809 or with 
β-actin as a loading control. Size markers are indicated in KDa. Right panel scatter plot showing relative 
density of RyR2 phosphorylation levels under these conditions. Band densities were normalised to β-
actin loading controls in each lane and expressed relative to phosphorylation by PKA. Data are 
displayed as mean ± SD (n = 3). 
 
Figure 6. Zn2+ potentiates RyR2 activity in Mg23-knockout mice. (A) Representative Ca2+ current 
fluctuations from bilayer experiments using cardiac SR vesicles isolated from wild type and Mg23-
knockout mice. Functional MG23-channel gating is observed in wild type experiments but not in Mg23-
knockout experiments. Open (O) and closed (C) states are indicated. Holding potential was 0 mV and 
Ca2+ was used as the permeant ion. Cytosolic free Ca2+ was 5 µM. (B) Scatter plot showing noise 
analysis data from wild type experiments where only MG23-mediated Ca2+-currents were observed. 
Mean average current is shown following incremental addition of Zn2+ to the cis-chamber. (C) 
Representative Ca2+ current fluctuations from bilayer experiments using cardiac SR vesicles isolated 
from Mg23-knockout mice, showing functional RyR2 channel gating in the absence and  presence of 1 
nM Zn2+ added to the cis-chamber. Lower panel scatter plot showing RyR2-channel open probability 
under these conditions. (D) Paired all-points amplitude histograms under conditions described in (C). 
Data shown are mean ± SD, n=3, with (*) and (**) indicating a significant differences (p<0.05 and 
p<0.01), respectively from control. 
 
 
Figure 7: Effects of Zn2+ on Ca2+ levels in BAPTA treated recording solutions. The free [Ca2+] of 
our TRIS/HEPES solution prior to the addition of BAPTA was determined using a Ca2+- selective 
electrode. In order to lower the [Ca2+] of our TRIS/HEPES solution, BAPTA was added until the 
measured free [Ca2+] was 100 nM. Incremental increase of Zn2+ in the range 100 pM - 100 µM was 
Zn2+ and SR Ca2+ leak 
15 
 
added as ZnCl2 to the BAPTA-treated solution and shown to have no significant effect until the [Zn2+] 
≥ 10 µM. Data are displayed as mean ± SD, n= 3. (**) indicates significance (p≤ 0.01) when compared 
to 100 nM [Ca2+]. 
 
 
Table 1: MG23 gating is revealed by pathophysiological concentrations Zn2+. Mean Gaussian fits 
of paired all points amplitude histograms constructed from bilayer experiments using native SR vesicle 
preparations in the absence and presence of 1 nM Zn2+. Bilayers were voltage clamped at 0 mV and 
Ca2+ was the permeant ion. Data are displayed as mean ± SD, n=3. 
 
 
Table 2: Fit of the all points amplitude histogram constructed from Mg23-KO mice using Ca2+ as 
the permeant ion. Mean Gaussian fits of paired all points amplitude histograms constructed from 
bilayer experiments using SR vesicles prepared from Mg23-knockout mice in the absence and presence 
of 1 nM Zn2+. Bilayers were voltage clamped at 0 mV and Ca2+ was the permeant ion. Data are displayed 
as mean ± SD, n=3. 
 
 
Table 3: Calculated free [Zn2+] and [Ca2+] in BAPTA-treated TRIS/HEPES solutions. Free Zn2+ 
calculations were performed using the MIQUV program. Tris protonation and Zn2+ stability constants 
were taken from Bolgni et al (65). Calculations were performed using the ionic composition of 
TRIS/HEPES recording solutions at room temperature (22 ± 2 oC).  
  



































































Figure 7  






































Gaussian fits of all-points amplitude histograms 



















1 -0.65 -3.78 - -0.167 -2.53 -3.76 
2 -0.39 -4.24 - -0.489 -1.62 -4.41 
3 -0.36 -4.07 - 0.3 -1.87 -4.4 
Mean ± SD -0.47 ± 0.2 -4.03 ± 0.2 - -0.12 ± 0.4 -2 ± 0.5 -4.19 ± 0.4 
Bilayers containing RyR2 only 
  Control   1 nM Zn2+  












1 -0.38 -4.22 - -0.41 -3.8 - 
2 -0.25 -3.88 - -0.04 -4.22 - 
3 0.06 - - -0.31 -4.14 - 
Mean ± SD -0.19 ± 0.2 -4.05 ± 0.2 - -0.25 ± 0.2 -4.05 ± 0.2 - 

















































Gaussian fits of amplitude histograms from mg23-KO mice 
 
Control 1 nM Zn2+ 
 
Peak 1 (pA) Peak 2 (pA) Peak 1 (pA) Peak 2 (pA) 
1 -0.0035 -4.45 -0.15 -3.61 
2 -0.53 -3.57 -0.21 -4.08 
3 0.25 -4.59 -0.17 -4.09 
Mean ± SD -0.09 ± 0.4 -4.2 ± 0.6 -0.18 ± 0.03 -3.93 ± 0.3 






















0.109 0.000204 91.3 
1.009 0.0019 91.4 
10 0.0188 91.6 
50 0.0946 92.4 
100 0.192 93.5 
1000 2.43 118 
10000 1290 2600 
 
